Exercise 13–19
Scenario 1
Scenario 2
No disclosure is required because an FDA claim is as yet unasserted, and an
Scenario 3
A disclosure note is required because an FDA claim is as yet unasserted, but an
assessment is probable. Since an unfavorable outcome is not thought to be
probable in the event of an assessment, no accrual is needed, but since an
Scenario 4
Accrual of the loss is required because an FDA claim is as yet unasserted, but
an assessment is probable. Since an unfavorable outcome also is thought to be
probable in the event of an assessment, accrual is needed. Keep in mind,